project id: TCGA-THCA; case submitter id: TCGA-EL-A3H7; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.71; normal tumor genotype snp match: Yes; age at index: 36; days to birth: -13407; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1966; age at diagnosis: 13407; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage I; ajcc pathologic t: T3; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4228.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2002; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3506; days to sample procurement: 0; specimen type: Solid Tissue; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent stromal cells: 0.0;